Aceon

• Recruiting NCT NCT02735707

  Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

  Not yet reported UMC Utrecht 20000 participants Est. completion 2028-02 408 sites
  Other conditions: Community-acquired Pneumonia, Influenza, COVID-19
  View official trial listing →
• Recruiting NCT NCT02817360

  NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients

  Not yet reported Martin Huelsmann 2400 participants Est. completion 2026-12 21 sites
  Type 2 diabetes Other conditions: Heart Diseases
  View official trial listing →
• Recruiting NCT NCT04980716

  Early Specialized Cardiovascular Intervention Based on Impedance Cardiography in Locally Advanced Non-small Cell Lung Cancer Patients

  Not yet reported Sun Yat-sen University 524 participants Est. completion 2026-07-01 1 site Stand-alone
  Other conditions: Non-small Cell Lung Cancer, Cardiovascular Complication
  View official trial listing →
• Recruiting NCT NCT05498675

  Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study

  Beijing Friendship Hospital 180 participants Est. completion 2027-06-30 1 site
  Other conditions: Sacubitril/Valsartan, Hypertension, Obesity
  View official trial listing →
• Recruiting NCT NCT05780710

  OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake

  Not yet reported Aktiia SA 35 participants Est. completion 2026-12-31 3 sites
  Other conditions: Hypertension
  View official trial listing →
• Recruiting NCT NCT07259733

  Rapid Management of Resistant Hypertension in the Public Health System (Fast Control)

  Not yet reported Instituto Dante Pazzanese de Cardiologia 142 participants Est. completion 2026-12-31 1 site Stand-alone
  Other conditions: Apparent Resistant Hypertension, Hypertension, High Blood Pressure
  View official trial listing →
• Status unknown NCT NCT00122811

  The Hypertension in the Very Elderly Trial (HYVET)

  Not yet reported Imperial College London 4000 participants Est. completion 2008-10 7 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00128518

  IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs

  Not yet reported Hospices Civils de Lyon 139 participants Est. completion 2010-09 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00145925

  Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 Diabetes

  Not yet reported The George Institute 11140 participants Est. completion 2008-03 5 sites
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT00202553

  S90652 in Paediatric Hypertension

  Not yet reported Institut de Recherches Internationales Servier 50 participants Est. completion 2006-12 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00202592

  S90652 in Paediatric Hypertension

  Not yet reported Institut de Recherches Internationales Servier 50 participants Est. completion 2010-04 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT00231803

  The Canadian Prevention of Renal and Cardiovascular Endpoints Trial

  Not yet reported Brendan Barrett 474 participants Est. completion 2008-06 5 sites Stand-alone
  Chronic kidney disease
  View official trial listing →
• Completed NCT NCT00292162

  Curing Atrial Fibrillation in Heart Failure

  Not yet reported NHS Greater Glasgow and Clyde 41 participants Est. completion 2009-07 1 site
  Heart failure Other conditions: Atrial Fibrillation
  View official trial listing →
• Terminated NCT NCT00402376

  Evaluation of Myocardial Improvement in Patients Supported by Ventricular Assist Device Under Optimal Pharmacological Therapy

  Not yet reported University Hospital, Strasbourg, France 20 participants 2 sites
  Heart failure
  View official trial listing →
• Completed NCT NCT00461903

  Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension

  Not yet reported Montreal Heart Institute 316 participants Est. completion 2015-09 1 site
  Other conditions: Essential Hypertension, Atrial Fibrillation
  View official trial listing →
• Completed NCT NCT00485368

  Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome

  Not yet reported Bayside Health 17 participants Est. completion 2006-09
  Other conditions: Marfan Syndrome
  View official trial listing →
• Completed NCT NCT00684489

  Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension

  Not yet reported Medical University of South Carolina 52 participants Est. completion 2005-09
  Other conditions: Hypertension
  View official trial listing →
• Terminated NCT NCT00915928

  Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors

  Not yet reported Odense University Hospital 47 participants Est. completion 2012-06
  Other conditions: Hematoma, Subdural, Chronic
  View official trial listing →
• Completed NCT NCT01012687

  Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions

  Not yet reported Roxane Laboratories 48 participants Est. completion 2007-05 1 site
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT01013155

  Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions

  Not yet reported Roxane Laboratories 48 participants Est. completion 2007-05 1 site
  Other conditions: Essential Hypertension
  View official trial listing →
• Status unknown NCT NCT01016886

  Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research

  Not yet reported, Not yet reported University of Alberta 99 participants Est. completion 2016-09 1 site Stand-alone
  Heart failure Other conditions: Breast Cancer
  View official trial listing →
• Completed NCT NCT01062451

  An ACE Inhibitor (Perindopril) or an Angiotensin Receptor Blocker (Candesartan) as a Treatment for Methamphetamine Dependence

  Not yet reported Baylor College of Medicine 80 participants Est. completion 2013-11-20 1 site
  Other conditions: Methamphetamine Dependence, Methamphetamine Abuse, Substance Abuse
  View official trial listing →
• Withdrawn NCT NCT01089452

  Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study

  Not yet reported Monash University 1 site
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01101009

  Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood Pressure

  Not yet reported Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 486 participants Est. completion 2012-12 15 sites
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT01118520

  AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK)

  Not yet reported Imperial College London 224 participants Est. completion 2015-04 9 sites
  Other conditions: Abdominal Aortic Aneurysm
  View official trial listing →
• Completed NCT NCT01219413

  Influence of Aliskiren on Proteinuria

  Not yet reported Medical University of Gdansk 16 participants Est. completion 2010-09 1 site Stand-alone
  Chronic kidney disease Other conditions: Proteinuria, Blood Pressure
  View official trial listing →
• Completed NCT NCT01295047

  Comparison of Medical Therapies in Marfan Syndrome.

  Not yet reported Cardiff University 18 participants Est. completion 2008-12 1 site
  Other conditions: Marfan Syndrome
  View official trial listing →
• Completed NCT NCT01556997

  Perindopril Amlodipine for the Treatment of Hypertension

  Not yet reported Symplmed Pharmaceuticals LLC 837 participants Est. completion 2013-02 48 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT01575652

  Effects of Aceis on Peritoneal Protein Loss and Solute Transport in pd Patients

  Not yet reported Turkish Nephrology Association 43 participants Est. completion 2009-01
  Other conditions: Disorders Associated With Peritoneal Dialysis
  View official trial listing →
• Terminated NCT NCT01583114

  PREclinical Mutation CARriers From Families With DIlated Cardiomyopathy and ACE Inhibitors

  Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 6 participants Est. completion 2014-01 7 sites Stand-alone
  Other conditions: Dilated Cardiomyopathy
  View official trial listing →
• Completed NCT NCT01669434

  Chronic Angiotensin Converting Enzyme Inhibitors in Intermediate Risk Surgery

  Not yet reported University of Nebraska 291 participants Est. completion 2016-12-01 1 site
  Other conditions: Hypotension on Induction
  View official trial listing →
• Completed NCT NCT01682577

  Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition

  Not yet reported Dexa Medica Group 18 participants Est. completion 2008-12 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Status unknown NCT NCT01715584

  Is There an Adverse Drug Reaction Between Renin-Angiotensin System Blockade and Inhaled Anesthetics

  Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80 participants Est. completion 2019-12-31 1 site
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT01819441

  Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients

  Not yet reported Yining Huang 1200 participants Est. completion 2016-12 1 site Stand-alone
  Other conditions: Cerebral Small Vessel Diseases
  View official trial listing →
• Terminated NCT NCT01867047

  ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients

  Not yet reported Duke University 59 participants Est. completion 2016-06-24 1 site Stand-alone
  Other conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors, Hypotension
  View official trial listing →
• Completed NCT NCT01891513

  ACE Inhibitors Combined With Exercise for Seniors - Pilot Study

  University of Florida 104 participants Est. completion 2017-06 1 site
  Other conditions: Hypertension, Aging
  View official trial listing →
• Withdrawn NCT NCT01948232

  Pilot Study of Perindopril in Childhood Cancer Survivors

  Not yet reported The Hospital for Sick Children Est. completion 2015-07 1 site Stand-alone
  Other conditions: Childhood Cancer Survivors
  View official trial listing →
• Terminated NCT NCT02085265

  Telmisartan vs. Perindopril in Mild-Moderate Alzheimer's Disease Patients

  Not yet reported Sunnybrook Health Sciences Centre 23 participants Est. completion 2025-02-28 10 sites
  Other conditions: Alzheimer's Disease
  View official trial listing →
• Status unknown NCT NCT02213224

  Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver Disease

  Not yet reported Nanfang Hospital, Southern Medical University 180 participants Est. completion 2017-09 1 site Stand-alone
  MASLD
  View official trial listing →
• Status unknown NCT NCT02299310

  Effect of Valsartan vs Perindopril on HOMA-IR Index in Patients With Chronic Kidney Disease

  Not yet reported Chinese PLA General Hospital 60 participants Est. completion 2015-12 1 site
  Chronic kidney disease
  View official trial listing →
• Completed NCT NCT02308202

  DOXAZOSIN FOR PTSD

  Not yet reported Baylor College of Medicine 30 participants Est. completion 2014-06-30 1 site
  Other conditions: PTSD
  View official trial listing →
• Completed NCT NCT02355821

  Comparative Effects of Moxonidine on Bone Metabolism, Vascular and Cellular Aging in Hypertensive Postmenopausal Women

  Not yet reported National Research Center for Preventive Medicine 114 participants Est. completion 2018-07-10 1 site Stand-alone
  Other conditions: Osteopenia, Arterial Hypertension
  View official trial listing →
• Completed NCT NCT02449811

  RAS Peptide Profiles in Patients With Arterial Hypertension

  Insel Gruppe AG, University Hospital Bern 107 participants Est. completion 2018-11 1 site
  Other conditions: Essential Hypertension
  View official trial listing →
• Status unknown NCT NCT02502110

  Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation

  Not yet reported The Third Xiangya Hospital of Central South University 346 participants Est. completion 2019-06
  Other conditions: Paroxysmal Atrial Fibrillation
  View official trial listing →
• Completed NCT NCT02651415

  Phase II Study of Perindopril and Regorafenib in mCRC

  Not yet reported British Columbia Cancer Agency 12 participants Est. completion 2018-11-07 1 site Stand-alone
  Other conditions: Metastatic Colorectal Cancer
  View official trial listing →
• Completed NCT NCT02655029

  Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination

  Servier Hellas Pharmaceuticals Ltd. 2285 participants Est. completion 2016-12-21 1 site
  Other conditions: Adherence to Medication Regime, Hypertensive Disease
  View official trial listing →
• Status unknown NCT NCT02710539

  Once-daily Fixed Combination of Three Antihypertensive Drugs

  Not yet reported University of Roma La Sapienza 100 participants Est. completion 2020-03 1 site
  Other conditions: Arterial Hypertension
  View official trial listing →
• Status unknown NCT NCT02710552

  Low-dose Combination of Three Antihypertensive Drugs

  Not yet reported University of Roma La Sapienza 100 participants Est. completion 2020-03 1 site
  Other conditions: Arterial Hypertension
  View official trial listing →
• Completed NCT NCT02729441

  Perindopril vs Ramipril for Persistence in MAU Reduction Study

  Not yet reported Sunnybrook Health Sciences Centre 23 participants Est. completion 2012-12 1 site Stand-alone
  Other conditions: Diabetes, Microalbuminuria
  View official trial listing →
• Completed NCT NCT02742467

  Comparison of Three Combination Therapies in Lowering Blood Pressure in Black Africans

  Not yet reported University of Abuja 702 participants Est. completion 2018-06-01 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Terminated NCT NCT02777489

  Influence of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects

  Not yet reported Gene PreDiT 140 participants Est. completion 2017-04-27 13 sites Stand-alone
  Other conditions: Obesity
  View official trial listing →
• Completed NCT NCT02995954

  Fixed vs Free Dose of ACEi/CCB Combination Therapy

  Not yet reported Guido Iaccarino 100 participants Est. completion 2015-12 1 site
  Other conditions: Hypertension
  View official trial listing →
• Withdrawn NCT NCT03047538

  Fixed Combination for Lipid and Blood Pressure Control

  Not yet reported Charles University, Czech Republic Est. completion 2019-12-31 1 site
  Other conditions: Arterial Hypertension, Dyslipidemias, Blood Pressure, Lipid Metabolism Disorders
  View official trial listing →
• Completed NCT NCT03246555

  Fimasartan in the Senior Subjects

  Not yet reported Boryung Pharmaceutical Co., Ltd 241 participants Est. completion 2019-12-09 1 site
  Other conditions: The Elderly (≥ 70 Years) With Essential Hypertension
  View official trial listing →
• Status unknown NCT NCT03249285

  Pharmacogenomics of Hypertension Personalized Medicine (PGX-HT)

  Not yet reported Ospedale San Raffaele 300 participants Est. completion 2018-11 3 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03295734

  ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension

  Not yet reported University of Alabama at Birmingham 223 participants Est. completion 2024-09-19 2 sites
  Other conditions: Hypertension, Aging, Sedentary Lifestyle
  View official trial listing →
• Completed NCT NCT03393715

  Effect of Morning Versus Evening Perindopril on Blood Pressure Control in People With Type 2 Diabetes

  Not yet reported Yaounde Central Hospital 20 participants Est. completion 2016-08 Stand-alone
  Type 2 diabetes Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT03502031

  Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy

  Not yet reported James A. Tumlin, MD 72 participants Est. completion 2024-10-01 2 sites
  Chronic kidney disease Other conditions: Renal Insufficiency, Chronic
  View official trial listing →
• Completed NCT NCT03722524

  The Use of TrIple Fixed-dose Combination in the Treatment of Arterial Hypertension

  Servier Russia 1247 participants Est. completion 2019-07-17 51 sites
  Other conditions: Arterial Hypertension
  View official trial listing →
• Completed NCT NCT03730116

  Assessment of the Efficacy and Tolerability of the Fixed-dose Combination of Bisoprolol/Perindopril

  Servier Russia 1909 participants Est. completion 2019-10-24 1 site
  Other conditions: Arterial Hypertension, CHD - Coronary Heart Disease
  View official trial listing →
• Completed NCT NCT03738761

  Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/Amlodipine

  Not yet reported KRKA 471 participants Est. completion 2019-09-27 34 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03747978

  Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes

  Not yet reported Yaounde Central Hospital 30 participants Est. completion 2017-05-30 1 site Stand-alone
  Type 2 diabetes Other conditions: Hypertension
  View official trial listing →
• Completed NCT NCT03921736

  Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.

  Not yet reported Anna Posadzy-Małaczyńska 180 participants Est. completion 2005-11-17 Stand-alone
  Other conditions: Hypertension, Hyperuricemia, Menopause
  View official trial listing →
• Status unknown NCT NCT04023565

  Moxonidine + Perindopril in Hypertensive Patients With Metabolic Syndrome

  Not yet reported Sergey V. Nedogoda 120 participants Est. completion 2020-12-30 1 site Stand-alone
  Metabolic syndrome Other conditions: Arterial Hypertension
  View official trial listing →
• Completed NCT NCT04036409

  Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Stroke Patients

  Not yet reported Hospital Israelita Albert Einstein 4368 participants Est. completion 2026-07-08 30 sites Stand-alone
  Cardiovascular disease Other conditions: Blood Pressure, Cognitive Impairment, Vascular Diseases
  View official trial listing →
• Completed NCT NCT04040634

  Optimal Blood Pressure for the prevenTIon of Major vAscuLar Events in Patients With DIABETES Mellitus (OPTIMAL-DIABETES)

  Not yet reported Hospital Israelita Albert Einstein 9476 participants Est. completion 2026-07-08 32 sites Stand-alone
  Cardiovascular disease Other conditions: Diabetes Mellitus, High Blood Pressure, Cognitive Impairment
  View official trial listing →
• Status unknown NCT NCT04148820

  One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease

  Not yet reported University of Roma La Sapienza 100 participants Est. completion 2021-10-31 2 sites Stand-alone
  Other conditions: Ischemic Heart Disease
  View official trial listing →
• Completed NCT NCT04222686

  Evaluation of Losartan and Perindopril in Blacks Type 2 Diabetics Patients

  Not yet reported Yaounde Central Hospital 23 participants Est. completion 2018-04-30 1 site
  Type 2 diabetes
  View official trial listing →
• Completed NCT NCT04254042

  Comparative Effects of Perindopril and Zofenopril on Blood Pressure Control and Oxidative Status Blacks Hypertensive Patients.

  Not yet reported Yaounde Central Hospital 24 participants Est. completion 2019-05-01 1 site
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT04306627

  Effect of Atorvastatin on Carotid Intima Media Thickness

  Not yet reported Yerevan State Medical University 200 participants Est. completion 2021-02-28
  Other conditions: Essential Hypertension, Hypercholesterolemia
  View official trial listing →
• Suspended NCT NCT04330300

  Coronavirus (COVID-19) ACEi/ARB Investigation

  Not yet reported National University of Ireland, Galway, Ireland 2414 participants Est. completion 2021-12-01 1 site
  Other conditions: Hypertension, COVID-19
  View official trial listing →
• Status unknown NCT NCT04342351

  Early Treatment of ARNI on Myocardial Remodeling and Progress

  Not yet reported RenJi Hospital 280 participants Est. completion 2021-12-30 1 site
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT04467931

  ACEI or ARB and COVID-19 Severity and Mortality in US Veterans

  University of Utah 22213 participants Est. completion 2020-12-31 1 site
  Other conditions: Hypertension, COVID
  View official trial listing →
• Status unknown NCT NCT04484688

  Prestilol(Perindopril+Bisoprolol) in Therapy of Patients With Atrial Fibrilation

  Aversi Clinic 50 participants Est. completion 2021-12-01 2 sites
  Other conditions: Patient Participation
  View official trial listing →
• Completed NCT NCT04556058

  A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on an Empty Stomach in Healthy Subjects

  Not yet reported Sichuan Haisco Pharmaceutical Group Co., Ltd 32 participants Est. completion 2019-03-15 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04556110

  A Study on the Bioequivalence of Perindopril Tert-butylamine Tablets Taken on After Meals in Healthy Subjects

  Not yet reported Sichuan Haisco Pharmaceutical Group Co., Ltd 32 participants Est. completion 2019-03-15 1 site Stand-alone
  Other conditions: Healthy
  View official trial listing →
• Completed NCT NCT04588935

  Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer

  Not yet reported State Institution "Republican Scientific and Practical Center" Cardiology, Belarus 100 participants Est. completion 2023-02-07 1 site
  Other conditions: Women With Breast Cancer
  View official trial listing →
• Completed NCT NCT04591210

  The COVID-RASi Trial (COVID-19)

  Not yet reported Ottawa Heart Institute Research Corporation 372 participants Est. completion 2024-12-30 31 sites Stand-alone
  Cardiovascular disease Other conditions: COVID-19
  View official trial listing →
• Terminated NCT NCT04591808

  Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia

  Not yet reported Institut de Recherches Internationales Servier 146 participants Est. completion 2022-04-08 43 sites Stand-alone
  Other conditions: Dyslipidemias, Hypertension
  View official trial listing →
• Status unknown NCT NCT04647292

  European Blood Pressure Intensive Control After Stroke

  Not yet reported University College Dublin 142 participants Est. completion 2026-03 1 site Stand-alone
  Cardiovascular disease Other conditions: Transient Ischemic Attack
  View official trial listing →
• Completed NCT NCT04656847

  PRIDE. Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/Perindopril

  Servier Russia 504 participants Est. completion 2021-10-18 1 site
  Cardiovascular disease Other conditions: Arterial Hypertension
  View official trial listing →
• Status unknown NCT NCT05053893

  Roxadustat Combined With Sacubitril Valsartan Sodium Tablets in the Treatment of Cardiorenal Anemia Syndrome

  Not yet reported The Affiliated Hospital of Qingdao University 40 participants Est. completion 2022-09-01 1 site Stand-alone
  Other conditions: Cardio-Renal Syndrome
  View official trial listing →
• Completed NCT NCT05288400

  Evaluation of the Clinical Efficacy and Safety of Amlodipine 5mg/ Bisoprolol Fumarate 5mg /Perindopril Arginine 5mg Fixed-dose Combination in Capsule and Free Monotherapy at the Same Dose in Patients With Uncontrolled Essential Hypertension.

  Not yet reported Servier 150 participants Est. completion 2018-12-18 15 sites Stand-alone
  Other conditions: Essential Hypertension
  View official trial listing →
• Completed NCT NCT05464745

  Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers

  Not yet reported Darnitsa Pharmaceutical Company 42 participants Est. completion 2021-06-09 1 site Stand-alone
  Other conditions: Bioequivalence, Healthy Subjects
  View official trial listing →
• Completed NCT NCT05470764

  Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

  Not yet reported Darnitsa Pharmaceutical Company 52 participants Est. completion 2021-06-28 1 site Stand-alone
  Other conditions: Bioequivalence, Healthy Subjects
  View official trial listing →
• Completed NCT NCT05535595

  Precision Treatment With Angiotensin Converting Enzyme Inhibitor

  Not yet reported Yonsei University 77 participants Est. completion 2021-08-02 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT05564780

  Study of Early Pharmaceutical Intervention for Cardiovascular Disease Prevention in Stage 1 Hypertension

  Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 20000 participants Est. completion 2026-12-31 Stand-alone
  Cardiovascular disease
  View official trial listing →
• Completed NCT NCT05683301

  Treatment Optimisation for Blood Pressure With Single-Pill Combinations in India

  Not yet reported Centre for Chronic Disease Control, India 1981 participants Est. completion 2024-09-22 35 sites Stand-alone
  Other conditions: Primary Hypertension
  View official trial listing →
• Completed NCT NCT05764317

  Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)

  Servier Russia 409 participants Est. completion 2024-02-20 1 site
  Other conditions: Arterial Hypertension, HTN
  View official trial listing →
• Completed NCT NCT05820880

  Efficacy and Safety of Perindopril 5 mg / Indapamide 1.25 mg / Amlodipine 5 mg Fixed Combination in Hypertension

  Not yet reported Institut de Recherches Internationales Servier 532 participants Est. completion 2022-02-23 42 sites Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT05940909

  Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions

  Not yet reported Pharmtechnology LLC 50 participants Est. completion 2023-11-17 1 site
  Other conditions: Bioequivalence
  View official trial listing →
• Status unknown NCT NCT06213610

  Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions

  Not yet reported Pharmtechnology LLC 50 participants Est. completion 2024-06-01 1 site
  Other conditions: Bioequivalence
  View official trial listing →
• Completed NCT NCT06259175

  Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)

  Servier Russia 396 participants Est. completion 2025-06-01 1 site
  Other conditions: Arterial Hypertension, HTN
  View official trial listing →
• Status unknown NCT NCT06275763

  Optimal Medical Treatment of Difficult-to-treat Hypertension

  Not yet reported National Institute of Cardiology, Warsaw, Poland 2500 participants Est. completion 2025-12-31 1 site Stand-alone
  Other conditions: Hypertension
  View official trial listing →
• Status unknown NCT NCT06341101

  Timely Recovery After Subclinical Heart Failure

  Not yet reported Academisch Ziekenhuis Maastricht 130 participants Est. completion 2026-03-01 1 site Stand-alone
  Heart failure Other conditions: Diastolic Dysfunction
  View official trial listing →
• Status unknown NCT NCT06515678

  Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

  Groupe Hospitalier Pitie-Salpetriere 9464 participants Est. completion 2024-08-31 2 sites
  Other conditions: Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab, Hypertension
  View official trial listing →
• Completed NCT NCT06704815

  Observational Cohort Study Evaluating the Effectiveness of an Educational Program (NGAYDAUTIEN) in Combination With Perindopril and Amlodipine Single-Pill Combination in Hypertensive Patients naïve of Antihypertensive Treatments.

  Servier Affaires Médicales 400 participants Est. completion 2024-06-12 1 site
  Other conditions: Hypertension
  View official trial listing →
• Not yet recruiting NCT NCT07262710

  Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study

  First Teaching Hospital of Tianjin University of Traditional Chinese Medicine 13656 participants Est. completion 2026-08-19
  Cardiovascular disease
  View official trial listing →
• Enrolling by invitation NCT NCT07547878

  Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

  Not yet reported Baylor Research Institute 64 participants Est. completion 2029-03-31 1 site
  Chronic kidney diseaseType 2 diabetes
  View official trial listing →

Not yet reported.

Not yet reported.

• ClinicalTrials.gov — NCT07547878

Also known as: Aceon, Perindopril

No related coverage yet.